| Brian W Hayes, MD | |
|
22 Bramhall St, Portland, ME 04102-3134 | |
| (207) 662-4735 | |
| (207) 662-6388 |
| Full Name | Brian W Hayes |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 22 Bramhall St, Portland, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831759430 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085N0700X | Radiology - Neuroradiology | 279115 (Massachusetts) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | MD26413 (Maine) | Primary |
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669488011 PECOS PAC ID: 7618871245 Enrollment ID: O20040423000266 |
News Archive
Johnson & Johnson today announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson.
Leading HIV experts today called on the global HIV community to intensify collaboration on tuberculosis control, to prevent the deaths of a quarter of a million people living with HIV (PLHIV) a year.
"The nation's largest public hospital system plans to slash its work force—including doctors and nurses—by about 10% over two years as government aid drops and the number of uninsured patients jumps," The Wall Street Journal reports.
Commenting on second quarter 2010 performance, Chairman, President and CEO Jai Nagarkatti said: "Our earnings for the second quarter of 2010 continued the strong performance achieved in this year's first quarter. We are very pleased with this performance that drove our increase in diluted EPS for the first half of 2010 to 18%. Consistent with our first quarter 2010 experience, conditions were favorable in several of our markets.
Solar cells, quantum computing and photodynamic cancer therapy. These all involve molecules switching between magnetic and nonmagnetic forms.
› Verified 7 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669488011 PECOS PAC ID: 7618871245 Enrollment ID: O20040423000305 |
News Archive
Johnson & Johnson today announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson.
Leading HIV experts today called on the global HIV community to intensify collaboration on tuberculosis control, to prevent the deaths of a quarter of a million people living with HIV (PLHIV) a year.
"The nation's largest public hospital system plans to slash its work force—including doctors and nurses—by about 10% over two years as government aid drops and the number of uninsured patients jumps," The Wall Street Journal reports.
Commenting on second quarter 2010 performance, Chairman, President and CEO Jai Nagarkatti said: "Our earnings for the second quarter of 2010 continued the strong performance achieved in this year's first quarter. We are very pleased with this performance that drove our increase in diluted EPS for the first half of 2010 to 18%. Consistent with our first quarter 2010 experience, conditions were favorable in several of our markets.
Solar cells, quantum computing and photodynamic cancer therapy. These all involve molecules switching between magnetic and nonmagnetic forms.
› Verified 7 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023619939 PECOS PAC ID: 7618871245 Enrollment ID: O20210126001672 |
News Archive
Johnson & Johnson today announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson.
Leading HIV experts today called on the global HIV community to intensify collaboration on tuberculosis control, to prevent the deaths of a quarter of a million people living with HIV (PLHIV) a year.
"The nation's largest public hospital system plans to slash its work force—including doctors and nurses—by about 10% over two years as government aid drops and the number of uninsured patients jumps," The Wall Street Journal reports.
Commenting on second quarter 2010 performance, Chairman, President and CEO Jai Nagarkatti said: "Our earnings for the second quarter of 2010 continued the strong performance achieved in this year's first quarter. We are very pleased with this performance that drove our increase in diluted EPS for the first half of 2010 to 18%. Consistent with our first quarter 2010 experience, conditions were favorable in several of our markets.
Solar cells, quantum computing and photodynamic cancer therapy. These all involve molecules switching between magnetic and nonmagnetic forms.
› Verified 7 days ago
| Entity Name | Spectrum Healthcare Partners Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417613456 PECOS PAC ID: 7618871245 Enrollment ID: O20211213000919 |
News Archive
Johnson & Johnson today announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson.
Leading HIV experts today called on the global HIV community to intensify collaboration on tuberculosis control, to prevent the deaths of a quarter of a million people living with HIV (PLHIV) a year.
"The nation's largest public hospital system plans to slash its work force—including doctors and nurses—by about 10% over two years as government aid drops and the number of uninsured patients jumps," The Wall Street Journal reports.
Commenting on second quarter 2010 performance, Chairman, President and CEO Jai Nagarkatti said: "Our earnings for the second quarter of 2010 continued the strong performance achieved in this year's first quarter. We are very pleased with this performance that drove our increase in diluted EPS for the first half of 2010 to 18%. Consistent with our first quarter 2010 experience, conditions were favorable in several of our markets.
Solar cells, quantum computing and photodynamic cancer therapy. These all involve molecules switching between magnetic and nonmagnetic forms.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian W Hayes, MD 324 Gannett Dr, Ste 200, South Portland, ME 04106-3266 Ph: (207) 482-7861 | Brian W Hayes, MD 22 Bramhall St, Portland, ME 04102-3134 Ph: (207) 662-4735 |
News Archive
Johnson & Johnson today announced the completion of the acquisition of Synthes, Inc. for a total purchase price of $19.7 billion in cash and stock. Synthes will now be integrated with the DePuy franchise to establish the DePuy Synthes Companies of Johnson & Johnson.
Leading HIV experts today called on the global HIV community to intensify collaboration on tuberculosis control, to prevent the deaths of a quarter of a million people living with HIV (PLHIV) a year.
"The nation's largest public hospital system plans to slash its work force—including doctors and nurses—by about 10% over two years as government aid drops and the number of uninsured patients jumps," The Wall Street Journal reports.
Commenting on second quarter 2010 performance, Chairman, President and CEO Jai Nagarkatti said: "Our earnings for the second quarter of 2010 continued the strong performance achieved in this year's first quarter. We are very pleased with this performance that drove our increase in diluted EPS for the first half of 2010 to 18%. Consistent with our first quarter 2010 experience, conditions were favorable in several of our markets.
Solar cells, quantum computing and photodynamic cancer therapy. These all involve molecules switching between magnetic and nonmagnetic forms.
› Verified 7 days ago
Michael O'malley Quinn, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2571 | |
Elena Leah Resnick, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2571 | |
Matthew D Ralston, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2571 | |
Jerald Christopher Kuhn, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Whitney Beeler, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-4735 Fax: 207-662-6388 | |
David Russell Langdon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 144 State St, Portland, ME 04101 Phone: 207-879-3000 | |
Ethan M Dobrow, MD Radiology Medicare: Medicare Enrolled Practice Location: 22 Bramhall St, Portland, ME 04102 Phone: 207-662-2526 |